These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11751726)

  • 21. Effect of angiotensin II blockade on cardiac hypertrophy and remodelling: a review.
    Dahlöf B
    J Hum Hypertens; 1995 Nov; 9 Suppl 5():S37-44. PubMed ID: 8583480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apoptosis signal-regulating kinase 1 plays a pivotal role in angiotensin II-induced cardiac hypertrophy and remodeling.
    Izumiya Y; Kim S; Izumi Y; Yoshida K; Yoshiyama M; Matsuzawa A; Ichijo H; Iwao H
    Circ Res; 2003 Oct; 93(9):874-83. PubMed ID: 14551246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiomyocyte apoptosis and cardiac angiotensin-converting enzyme in spontaneously hypertensive rats.
    Díez J; Panizo A; Hernández M; Vega F; Sola I; Fortuño MA; Pardo J
    Hypertension; 1997 Nov; 30(5):1029-34. PubMed ID: 9369251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Short-term hypoxia upregulated Mas receptor expression to repress the AT
    Chang RL; Chang CF; Ju DT; Ho TJ; Chang TT; Lin JW; Li JC; Cheng SM; Day CH; Viswanadha VP; Huang CY
    J Cell Biochem; 2018 Mar; 119(3):2742-2749. PubMed ID: 29052864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term administration of nifedipine attenuates cardiac remodeling and diastolic heart failure in hypertensive rats.
    Yamada T; Nagata K; Cheng XW; Obata K; Saka M; Miyachi M; Naruse K; Nishizawa T; Noda A; Izawa H; Kuzuya M; Okumura K; Murohara T; Yokota M
    Eur J Pharmacol; 2009 Aug; 615(1-3):163-70. PubMed ID: 19501083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. From left ventricular hypertrophy to congestive heart failure: management of hypertensive heart disease.
    Gradman AH; Alfayoumi F
    Prog Cardiovasc Dis; 2006; 48(5):326-41. PubMed ID: 16627048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Hypertensive Myocardium: From Microscopic Lesions to Clinical Complications and Outcomes.
    Moreno MU; Eiros R; Gavira JJ; Gallego C; González A; Ravassa S; López B; Beaumont J; San José G; Díez J
    Med Clin North Am; 2017 Jan; 101(1):43-52. PubMed ID: 27884234
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The fibrosis-cell death axis in heart failure.
    Piek A; de Boer RA; Silljé HH
    Heart Fail Rev; 2016 Mar; 21(2):199-211. PubMed ID: 26883434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential role of TIMP2 and TIMP3 in cardiac hypertrophy, fibrosis, and diastolic dysfunction.
    Fan D; Takawale A; Basu R; Patel V; Lee J; Kandalam V; Wang X; Oudit GY; Kassiri Z
    Cardiovasc Res; 2014 Jul; 103(2):268-80. PubMed ID: 24692173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of the calcium-sensing receptor in cardiomyocyte apoptosis via the sarcoplasmic reticulum and mitochondrial death pathway in cardiac hypertrophy and heart failure.
    Lu FH; Fu SB; Leng X; Zhang X; Dong S; Zhao YJ; Ren H; Li H; Zhong X; Xu CQ; Zhang WH
    Cell Physiol Biochem; 2013; 31(4-5):728-43. PubMed ID: 23711498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaccarin administration ameliorates hypertension and cardiovascular remodeling in renovascular hypertensive rats.
    Zhu X; Zhou Z; Zhang Q; Cai W; Zhou Y; Sun H; Qiu L
    J Cell Biochem; 2018 Jan; 119(1):926-937. PubMed ID: 28681939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of myocardial LIF receptor in experimental heart failure reduces cardiotrophin-1 cytoprotection. A role for neurohumoral agonists?
    López N; Varo N; Díez J; Fortuño MA
    Cardiovasc Res; 2007 Aug; 75(3):536-45. PubMed ID: 17559824
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiomyocyte death and renewal in the normal and diseased heart.
    Buja LM; Vela D
    Cardiovasc Pathol; 2008; 17(6):349-74. PubMed ID: 18402842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myocardial stiffness is determined by ventricular fibrosis, but not by compensatory or excessive hypertrophy in hypertensive heart.
    Yamamoto K; Masuyama T; Sakata Y; Nishikawa N; Mano T; Yoshida J; Miwa T; Sugawara M; Yamaguchi Y; Ookawara T; Suzuki K; Hori M
    Cardiovasc Res; 2002 Jul; 55(1):76-82. PubMed ID: 12062710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coronary reserve in experimental myocardial hypertrophy.
    Gosse P; Clementy J
    Eur Heart J; 1995 Aug; 16 Suppl I():22-5. PubMed ID: 8829953
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ginseng reverses established cardiomyocyte hypertrophy and postmyocardial infarction-induced hypertrophy and heart failure.
    Moey M; Gan XT; Huang CX; Rajapurohitam V; Martínez-Abundis E; Lui EM; Karmazyn M
    Circ Heart Fail; 2012 Jul; 5(4):504-14. PubMed ID: 22576957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-apoptosis in nonmyocytes and pro-autophagy in cardiomyocytes: two strategies against postinfarction heart failure through regulation of cell death/degeneration.
    Takemura G; Kanamori H; Okada H; Miyazaki N; Watanabe T; Tsujimoto A; Goto K; Maruyama R; Fujiwara T; Fujiwara H
    Heart Fail Rev; 2018 Sep; 23(5):759-772. PubMed ID: 29737434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reversal of interstitial fibroblast hyperplasia via apoptosis in hypertensive rat heart with valsartan or enalapril.
    Der Sarkissian S; Marchand EL; Duguay D; Hamet P; deBlois D
    Cardiovasc Res; 2003 Mar; 57(3):775-83. PubMed ID: 12618239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fibroblast apoptosis precedes cardiomyocyte mass reduction during left ventricular remodeling in hypertensive rats treated with amlodipine.
    Duguay D; Pesant S; Deschepper CF; deBlois D
    J Hypertens; 2007 Jun; 25(6):1291-9. PubMed ID: 17563544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Downregulation of apoptosis-inducing factor in harlequin mutant mice sensitizes the myocardium to oxidative stress-related cell death and pressure overload-induced decompensation.
    van Empel VP; Bertrand AT; van der Nagel R; Kostin S; Doevendans PA; Crijns HJ; de Wit E; Sluiter W; Ackerman SL; De Windt LJ
    Circ Res; 2005 Jun; 96(12):e92-e101. PubMed ID: 15933268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.